A comparative study between the disease characteristics in adult-onset and childhood-onset systemic lupus erythematosus in Egyptian patients attending a large university hospital

Abstract

Introduction

Disease features and laboratory abnormalities differ among adult-onset and childhood-onset systemic lupus erythematosus (aSLE and cSLE). Socioeconomic status both independent of, and in combination with, ethnicity influences the disease phenotype and outcome.

Objective

To compare the various disease features among patients with cSLE and aSLE in a limited monetary income Egyptian cohort attending a large free-of-charge university hospital. Patients and methods: Retrospective analysis of the medical records of 714 SLE patients attending Cairo University Hospitals from January 2000 to December 2019. Of them 602 (400 with aSLE and 202 with cSLE) were enrolled in the study.

Results

The mean age of disease onset was 28.27 ± 10.55 among aSLE patients compared to 12.88 ± 4.26 years among cSLE patients. Disease duration was 12.03 ± 5.05 and 4.14 ± 3.18 years in aSLE and cSLE, respectively. Female to male ratio was 15:1 among patients with aSLE, as compared to 2.67:1 among cSLE (<0.001). Arthritis (69%), oral ulcers (48.5%), neuropsychiatric (18.3%) and thrombotic manifestations of antiphospholipid syndrome (12%) were significantly more frequent in aSLE. On the other hand, renal (67.8%), serositis (49.6%), fever (49%), lymphopenia (40.6%), hemolytic anemia (38.6%), and discoid lupus (13.4%) were significantly more frequent in cSLE. Weight loss, malar rash, photosensitivity, thrombocytopenia, leucopenia and lymphadenopathy were not significantly different between the two groups. Hypocomplementemia, proteinuria, urinary sediments, hematuria were significantly more frequent in cSLE. For those patients with renal involvement, who underwent renal biopsy (58.3% in aSLE and 63.5% in cSLE), there was no significant difference with regard to the different histopathological classes. Anti-Smith, anti-cardiolipin antibodies and rheumatoid factor were significantly more frequent among aSLE patients, while anti-La antibodies were more frequent among cSLE patients.

Conclusion

Arthritis was the most common clinical manifestation over time in aSLE compared to renal involvement in cSLE. Renal disease tends to be more active in cSLE. The differences in disease manifestations between this cohort and other studies can be attributed to the ethnic and socioeconomic disparities.

Keywords

Systemic lupus erythematosus childhood adult Egyptian socioeconomic

Get full access to this article

View all access options for this article.

References

Livingston

Bonner

Pope

Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: a meta-analysis. Lupus 2011; 20: 1345–1355.

Brunner

Gladman

Ibanez

Urowitz

Silverman

ED.

Differences in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum 2008; 58: 556–562.

Hersh

von Scheven

Yazdany

, et al. Differences in long-term disease activity and treatment of adult patients with childhood and adult-onset systemic lupus erythematosus. Arthritis Rheum 2008; 61: 13–20.

Hoffman

Lauwerys

De Keyser

, et al. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus. Ann Rheum Dis 2009; 68: 412–415.

El Hadidi

Medhat

Abdel Baki

, et al. Characteristics of systemic lupus erythematosus in a sample of the Egyptian population: a retrospective cohort of 1109 patients from a single center. Lupus 2018; 27: 1030–1038.

González

Toloza

McGwin

Jr Alarcón

GS.

Ethnicity in systemic lupus erythematosus (SLE): its influence on susceptibility and outcomes. Lupus 2013; 22: 1214–1224.

Soares

Reis

Papi

Cardoso

CR.

Rate, pattern and factors related to damage in Brazilian systemic lupus erythematosus patients. Lupus 2003; 12: 788–794.

Vila

Alarcon

McGwin

Jr , et al. Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations. Rheumatology (Oxford) 2003; 43: 358–363.

Gladman

Urowitz

Rahman

Ibanez

Tam

LS.

Accrual of organ damage over time in patients with systemic lupus erythematosus. J Rheumatol 2003; 30: 1955–1959.

10.

Calvo-Alen

Reveille

Rodriguez-Valverde

, et al. Clinical, immunogenetic and outcome features of Hispanic systemic lupus erythematosus patients of different ethnic ancestry. Lupus 2003; 12: 377–385.

11.

Wang

Mayo

Fortin

PR.

The relationship between health-related quality of life and disease activity and damage in systemic lupus erythematosus. J Rheumatol 2001; 28: 525–532.

12.

Yurco

An Egyptological review. In: Lefkowitz

Rogers

(eds) Black athena revisited. Chapel Hill: University of North Carolina Press, 1996, pp.62–100.

13.

Petri

Perez-Gutthann

Longenecker

Hochberg

Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am J Med 1991; 91: 345–353.

14.

Molokhia

McKeigue

Systemic lupus erythematosus: genes versus environment in high risk populations. Lupus 2006; 15: 827–832.

15.

Al Dhanhani

Gignac

Fortin

PR.

Work disability in systemic lupus erythematosus. Arthritis Rheum 2009; 61: 378–385.

16.

Baker

Pope

Employment and work disability in systemic lupus erythematosus: a systematic review. Rheumatology (Oxford) 2009; 48: 281–284.

17.

Lau

Mak

The socioeconomic burden of SLE. Nat Rev Rheumatol 2009; 5: 400–404.

18.

Drenkard

Bao

Dennis

, et al. Burden of systemic lupus erythematosus on employment and work productivity: data from a large cohort in the southeastern United States. Arthritis Care Res (Hoboken) 2014; 66: 878–887.

19.

Gonzalez

Toloza

Alarcon

GS.

Impact of race and ethnicity in the course and outcome of systemic lupus erythematosus. Rheum Dis Clin North Am 2014; 40: 433–454.

20.

The American Psychological Association (APA), http//www.apa.org//.psychology topics//SocioeconomicStatus (October 2010) (accessed 18 September 2020).

21.

Hochberg

MC.

Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.

22.

Petri

Orbai

A-M

Alarcón

, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012; 64: 2677–2686.

23.

Bombardier

Gladman

Urowitz

Caron

Chang

CH.

Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum 1992; 35: 630–640.

24.

Miyakis

Lockshin

Atsumi

, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295–306.

25.

Silvia

Avcin

Taxonomy for systemic lupus erythematous with onset before adulthood. Arthritis Care Res (Hoboken) 2012; 64: 1187–1193.

26.

Hui-Yuen

Imundo

Avitabile

Kahn

Eichenfield

Levy

DM.

Early versus later onset childhood-onset systemic lupus erythematosus: clinical features, treatment and outcome. Lupus 2011; 20: 952–959.

27.

Al Arfaj

Khalil

Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia. Lupus 2009; 18: 465–473.

28.

Al Saleh

Jassim

ElSayed

Saleh

Harb

Clinical and immunological manifestations in 151 SLE patients living in Dubai. Lupus 2008; 17: 62–66.

29.

Uthman

Nasr

Kassak

Masri

AF.

Systemic lupus erythematosus in Lebanon. Lupus 1999; 8: 713–715.

30.

Alarcon

McGwin

Jr Petri

, et al.; PROFILE Study Group. Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus 2002; 11: 95–101.

31.

Pons-Estel

Catoggio

Cardiel

, et al.; Grupo Latinoamericano de Estudio del Lupus. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus. Medicine (Baltimore) 2004; 83: 1–17.

32.

Zhang

Leng

, et al.; CSTAR co-authors. Chinese SLE treatment and research group (CSTAR) registry: I. Major clinical characteristics of Chinese patients with systemic lupus erythematosus. Lupus 2013; 22: 1192–1199.

33.

Abdel-Nabi

Abdel-Noor

RA.

Comparison between disease onset patterns of Egyptian juvenile and adult systemic lupus erythematosus (single Centre experience). Lupus 2018; 27: 1039–1044.

34.

Carreno

Lopez-Longo

Monteagudo

, et al. Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus. Lupus 1999; 8: 287–292.

35.

Bader-Meunier

Armengaud

Haddad

, et al. Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study. J Pediatr 2005 May; 146: 648–653.

36.

Ramirez Gomez

Uribe Uribe

Osio Uribe

, et al. Childhood systemic lupus erythematosus in Latin America. The GLADEL experience in 230 children. Lupus 2008; 17: 596–604.

37.

Zappitelli

Duffy

Bernard

Gupta

IR.

Evaluation of activity, chronicity and tubulointerstitial indices for childhood lupus nephritis. Pediatr Nephrol 2008; 23: 83–91.

38.

Mina

Brunner

HI.

Pediatric lupus – are there differences in presentation, genetics, response to therapy, damage accrual compared to adult lupus?

Rheum Dis Clin North Am 2010; 36: 53–80.

39.

Abdul-Sattar

Abau-El-Magd

Association of perceived neighborhood characteristics, socioeconomic status, rural residency with health outcomes in Egyptian patients with systemic lupus erythematosus: single center study. Int J Rheum Dis 2017; 20: 2045–2052.

40.

Salah

Lotfy

Sabry

El-Hamshary

Taher

Systemic lupus erythematosus in Egyptian children. Rheumatol Int 2009; 29: 1463–1468.

41.

Gheita

Fawzy

Nour El-Din

El-Fishawy

HS.

Juvenile and adult onset systemic lupus erythematosus outcome in Egyptian patients. The Egyptian Rheumatologist (EJR) 2011; 33: 99–105.

42.

Mohamed

Abdel Aziz

Hassan

Shedid

Rasha Hassan El-Owaidy

Teama

MA.

Juvenile lupus: Different clinical and serological presentations compared to adult lupus in Egypt. The Egyptian Rheumatologist (EJR) 2018; 40: 55–58.

43.

Tucker

Uribe

Fernandez

, et al. Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus 2008; 17: 314–322.

44.

Font

Cervera

Espinosa

, et al. Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis 1998; 57: 456–459.

45.

Petri

Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?

Arthritis Rheum 2005; 52: 4003–4010.

46.

Jurencak

Fritzler

Tyrrell

Hiraki

Benseler

Silverman

Autoantibodies in pediatric systemic lupus erythematosus: ethnic grouping, cluster analysis, and clinical correlations. J Rheumatol 2009; 36: 416–421.

47.

Pluchinotta

Schiavo

Vittadello

Martini

Perilongo

Zulian

Distinctive clinical features of pediatric systemic lupus erythematosus in three different age classes. Lupus 2007; 16: 550–555.

48.

Kaiser

Cleveland

Criswell

LA.

Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort. Ann Rheum Dis 2009; 68: 238–241.